https://beyondcancer.com/contacthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-nitric-oxide-solid-tumors.webpfigurenitricoxidesolidtumorsfigurenitricoxidesolidtumorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-contact.jpgbgbannercontactbgbannercontact2025-03-25https://beyondcancer.com/disclaimerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner.jpgbgbannerbgbannerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-14https://beyondcancer.com/news/beyond-air-announces-30-million-of-committed-capital-inhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-air-affiliate-beyond-cancer-doses-initial-patient-in-first-in-human-phase-1-study-of-ultra-high-concentration-nitric-oxide-therapy-at-tel-aviv-sourasky-medical-cenhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-air-announces-two-appointments-to-beyond-cancer-board-of-directorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.comhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/videos/banner-video.mp4/medium.jpgbanner-videobanner-videohttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/videos/banner-video.mp418nonohttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-home-news.webpfigurehomenewsfigurehomenewshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-home-science.webpfigurehomesciencefigurehomesciencehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-03-28https://beyondcancer.com/news/beyond-cancer-selected-to-present-proffered-posters-discussing-data-from-the-uno-therapy-program-at-the-2023-aacr-nci-eortc-international-conference-on-molecular-targets-https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-selected-to-present-on-the-clinical-development-of-ultra-high-concentration-nitric-oxide-uno-therapy-at-the-2024-american-society-of-clinical-oncology-annuahttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-to-present-pre-clinical-data-for-ultra-high-concentration-nitric-oxide-therapy-at-the-2022-sitc-annual-meetinghttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-appoints-jedidiah-monson-m-d-as-chief-medical-officerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-presents-positive-first-in-human-clinical-data-for-ultra-high-concentration-nitric-oxide-uno-therapy-in-solid-tumors-during-the-society-for-immunotherapy-ofhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-announces-sponsored-research-agreement-with-stanford-and-appointment-of-frederick-m-dirbas-md-and-mark-d-pegram-md-to-scientific-advisory-boardhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-publishes-pre-clinical-data-in-cells-demonstrating-that-the-combination-of-ultra-high-concentration-nitric-oxide-uno-and-anti-mpd-1-therapy-improves-tumor-rhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/cells-12-02439-g006-1024x595.jpgcells1202439g0061024x595cells1202439g0061024x595https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/cells-12-02439-g004-1024x833.jpgcells1202439g0041024x833cells1202439g0041024x833https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/cells-12-02439-g002-1024x697.jpgcells1202439g0021024x697cells1202439g0021024x6972025-02-05https://beyondcancer.com/approachhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chart-breast-cancer-cells.svgchartbreastcancercellschartbreastcancercellshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-science-timeline-01.jpgfiguresciencetimeline01figuresciencetimeline01https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-science-timeline-03.jpgfiguresciencetimeline03figuresciencetimeline03https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/grphc-two-mice-cont-right.svggrphctwomicecontrightgrphctwomicecontrighthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/grphc-two-mice-right.svggrphctwomicerightgrphctwomicerighthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/grphc-two-mice-cont-left.svggrphctwomicecontleftgrphctwomicecontlefthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-science-dual-role.svgfiguresciencedualrolefiguresciencedualrolehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-blood-b-cells.svgchrtbloodbcellschrtbloodbcellshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-science.jpgbgbannersciencebgbannersciencehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-ct26-prim-sec-tumor-free-bar.svgchrtct26primsectumorfreebarchrtct26primsectumorfreebarhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-science-timeline-02.jpgfiguresciencetimeline02figuresciencetimeline02https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-survival-analysis.svgchrtsurvivalanalysischrtsurvivalanalysishttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chart-challenge-tumor-take.svgchartchallengetumortakechartchallengetumortakehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-nitric-oxide-solid-tumors.webpfigurenitricoxidesolidtumorsfigurenitricoxidesolidtumorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chart-survival.svgchartsurvivalchartsurvivalhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-tumor-analysis-14days.svgchrttumoranalysis14dayschrttumoranalysis14dayshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-primary-tumor-growth-results.svgchrtprimarytumorgrowthresultschrtprimarytumorgrowthresultshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chart-colon-cancer-cells.svgchartcoloncancercellschartcoloncancercellshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/diagram-mice-anti-mPD1.svgdiagrammiceantimPD1diagrammiceantimPD1https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/grphc-two-mice-left.svggrphctwomiceleftgrphctwomicelefthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/chrt-blood-t-cells.svgchrtbloodtcellschrtbloodtcellshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-science-timeline-04.jpgfiguresciencetimeline04figuresciencetimeline042025-03-25https://beyondcancer.com/news/beyond-air-announces-formation-of-beyond-cancerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-announces-new-preclinical-data-presented-at-american-association-for-cancer-research-aacr-showing-ultra-high-concentration-nitric-oxide-therapy-anti-tumor-ehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-phase-1-study-clears-cohort-1-in-patients-with-advanced-relapsed-or-refractory-unresectable-primary-or-metastatic-cutaneous-or-subcutaneous-solid-tumorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-to-present-initial-clinical-data-for-ultra-high-concentration-nitric-oxide-therapy-at-the-2023-sitc-annual-meetinghttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-announces-appointment-of-gavin-choy-pharmd-mba-as-chief-operating-officerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/careers/program-managerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-14https://beyondcancer.com/investors-mediahttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-investors.jpgbgbannerinvestorsbgbannerinvestorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-05-05https://beyondcancer.com/news/beyond-cancer-appoints-susan-howell-jones-cpa-as-chief-financial-officerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-to-present-two-posters-for-ultra-high-concentration-nitric-oxide-uno-therapy-at-the-2022-aacr-annual-meetinghttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/approach/publicationshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-publications.jpgbgbannerpublicationsbgbannerpublications2025-02-13https://beyondcancer.com/news/beyond-cancer-to-present-preclinical-data-of-ultra-high-concentration-nitric-oxide-uno-low-volume-therapy-at-the-2024-society-for-immunotherapy-of-cancer-sitc-annual-meethttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-to-present-two-abstracts-for-ultra-high-concentration-nitric-oxide-therapy-at-the-2022-aacr-annual-meetinghttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/careershttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-careers.jpgbgbannercareersbgbannercareers2025-02-14https://beyondcancer.com/news/beyond-cancer-presents-positive-preclinical-data-for-ultra-high-concentration-nitric-oxide-uno-therapy-in-solid-tumors-during-the-american-association-for-cancer-researchhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-publishes-pre-clinical-data-in-cancer-cell-international-demonstrating-its-tumor-ablation-method-utilizing-ultra-high-concentration-nitric-oxide-uno-inducedhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/26d99aea-0c22-4ac8-81fb-413d504afdfb.png26d99aea0c224ac881fb413d504afdfb26d99aea0c224ac881fb413d504afdfbhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/95e1d260-011a-4fd6-b8f4-93dcb36b34c1.png95e1d260011a4fd6b8f493dcb36b34c195e1d260011a4fd6b8f493dcb36b34c1https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-presents-first-in-class-clinical-data-showing-an-immunogenic-response-in-subjects-with-r-r-unresectable-solid-tumors-treated-with-ultra-high-concentration-nhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-announces-approval-by-the-israeli-ministry-of-health-to-conduct-a-phase-1b-clinical-trial-utilizing-low-volume-ultra-high-concentration-nitric-oxide-lv-uno-https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-home-news.webpfigurehomenewsfigurehomenews2025-02-12https://beyondcancer.com/abouthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/figure-nitric-oxide-solid-tumors.webpfigurenitricoxidesolidtumorsfigurenitricoxidesolidtumorshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Berk_-e1650582061536.webpBerke1650582061536Berke1650582061536https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/profile-robert.jpgprofilerobertprofileroberthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTMhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner-about.jpgbgbanneraboutbgbannerabouthttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Dvorak_-e1650580398575.webpDvorake1650580398575Dvorake16505803985752026-03-26https://beyondcancer.com/news/beyond-cancer-presents-promising-new-in-vivo-data-showing-ultra-high-concentration-nitric-oxide-therapy-uno-in-combination-with-anti-pd-1-during-the-society-for-immunothehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/news/beyond-cancer-presents-promising-preclinical-data-on-low-volume-ultra-high-concentration-nitric-oxide-lv-uno-therapy-at-the-2024-society-for-immunotherapy-of-cancer-sitc-https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/Picture1.jpgPicture1Picture1https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/Imported_Blog_Media/Picture2.jpgPicture2Picture2https://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-03-28https://beyondcancer.com/newshttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-04-02https://beyondcancer.com/news/beyond-cancer-presents-positive-preclinical-data-for-ultra-high-concentration-nitric-oxide-uno-in-combination-with-checkpoint-inhibitor-therapy-during-the-2023-aacr-nci-ehttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-05https://beyondcancer.com/privacyhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/bg-banner.jpgbgbannerbgbannerhttps://47959336.fs1.hubspotusercontent-na1.net/hubfs/47959336/BeyondCancer_February2025/images/Beyond-Cancer-TM.svgBeyondCancerTMBeyondCancerTM2025-02-14